Final ID: P-345
Truong Nam, Manwani Bharti, Mcconnell Bradley, Lee Dung-fang, Wang Jun, Zheng Mingjie, Xu Ying, Cheng Zixiu, Quinn Julianna, Phan Trinh, Chen Xiaotong, Zhu Jiajun, Chen Shuibing
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal AntibodyAhmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor